| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Revenue | $810.0M | +13.7% |
| R&D Expense | $51.9M | +14.1% |
| SG&A Expense | $116.6M | +8.0% |
| Operating Income | $94.3M | +47.7% |
| Pre-tax Income | $85.1M | +241.5% |
| Income Tax | $20.5M | +331.0% |
| Net Income | $64.6M | +302.5% |
| EPS (Basic) | $0.43 | +290.9% |
| EPS (Diluted) | $0.43 |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $391.7M | +33.8% |
| Short-term Investments | $2.0M | +107.9% |
| Accounts Receivable | $143.8M | -7.7% |
| Current Assets | $566.2M | +21.5% |
| Total Assets | $1.89B | -0.0% |
| Current Liabilities | $100.8M | -7.8% |
| Long-term Debt | $556.6M | +0.3% |
| Line Item | 2022-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $212.8M | +43.1% |
| Capital Expenditures | $6.2M | -15.7% |
| Investing Cash Flow | -$48.6M | +32.9% |
| Financing Cash Flow | -$59.2M | -192.6% |
| Free Cash Flow | $206.6M | +46.2% |
| +290.9% |
| Total Liabilities |
| $759.2M |
| +0.6% |
| Stockholders' Equity | $1.13B | -0.5% |